Peak of Covid-19 Case Increase: Factors Related to Acceptance of the Covid-19 Booster Among Adolescents

Santy Irene Putri; Arie Jefry Ka’arayeno; Siti Asiyah; Joel Rey Ugsang Acob

doi:10.30994/jnp.v9i1.917

Authors

Santy Irene Putri Politeknik Kesehatan Wira Husada Nusantara Malang https://orcid.org/0000-0001-8793-8541
Arie Jefry Ka’arayeno Universitas Tribhuwana Tunggadewi Malang https://orcid.org/0009-0004-7700-5536
Siti Asiyah Politeknik Kesehatan Kemenkes Malang https://orcid.org/0000-0002-4443-3129
Joel Rey Ugsang Acob Department of Nursing, Visayas State University, Visayas, Philippines https://orcid.org/0000-0002-3829-322X

DOI:

https://doi.org/10.30994/jnp.v9i1.917

Keywords:

adolescents, covid-19 increase, vaccine booster

Abstract

Background: The acceleration of booster vaccination targets a minimum of 50 percent people aged 18 years and above while still prioritizing high-risk groups, such as the elderly. This is crucial to extend the protection of the Covid-19 vaccine and ensure that there is no surge in cases in the future.

Purpose: This study aimed to analyze the determinant factors of Covid-19 booster acceptance among adolescents aged 18-24 years.

Methods: The present study adopted an analytic observation method with a cross-sectional approach. It took place in East Java and involved 1415 adolescents selected through a simple random sampling. The dependent variable was Covid-19 booster acceptance among these adolescents. The independent variables were age, education, gender, and family income. The data were obtained through a questionnaire. They processed using bivariate analysis to investigate the relationship between the dependent and independent variables. To determine the acceptance of adolescents towards Covid-19 booster, it used multivariate logistic regression.

Results: Age (OR= 1.71, CI 95% = 1.25 to 2.3, p= 0.001), education (OR= 1.56, CI 95% = 1.18 to 2.08, p= 0.002), gender (OR= 1.51, CI 95% = 0.14 to 1.99, p= 0.004), and family income (OR= 1.36, CI 95% = 0.10 to 1.85, p= 0.052) hold a statistically significant relationship with Covid-19 booster acceptance among adolescents.

Conclusion: Age, education, gender, and family income are factors affecting Covid-19 booster acceptance among adolescents. Government and other relevant stakeholders are expected to take comprehensive measures to increase Covid-19 booster vaccination among adolescents aged 18-24 years.

Downloads

Download data is not yet available.

References

Abdelmoneim, S. A., Sallam, M., Hafez, D. M., Elrewany, E., Mousli, H. M., Hammad, E. M., Elkhadry, S. W., Adam, M. F., Ghobashy, A. A., Naguib, M., Nour El-Deen, A. E. S., Aji, N., & Ghazy, R. M. (2022). COVID-19 Vaccine Booster Dose Acceptance: Systematic Review and Meta-Analysis. Tropical Medicine and Infectious Disease, 7(10), 46–71. https://doi.org/10.3390/tropicalmed7100298.

Beccia, F., Rossi, M. F., Amantea, C., Villani, L., Daniele, A., Tumminello, A., Aristei, L., Santoro, P. E., Borrelli, I., Ricciardi, W., Gualano, M. R., & Moscato, U. (2022). COVID-19 Vaccination and Medical Liability: An International Perspective in 18 Countries. Vaccines, 10(8), 1–14. https://doi.org/10.3390/vaccines10081275.

Bert, F., Scaioli, G., Vola, L., Accortanzo, D., Lo Moro, G., & Siliquini, R. (2022). Booster Doses of Anti COVID-19 Vaccines: An Overview of Implementation Policies among OECD and EU Countries. International Journal of Environmental Research and Public Health, 19(12). https://doi.org/10.3390/ijerph19127233.

Chan, P. S. fong, Lee, M. L. tin, Fang, Y., Yu, F. Y., Ye, D., Chen, S., Kawuki, J., Liang, X., & Wang, Z. (2023). Hesitancy to Receive the Second COVID-19 Vaccine Booster Dose among Older Adults in Hong Kong: A Random Telephone Survey. Vaccines, 11(2), 1–14. https://doi.org/10.3390/vaccines11020392.

Chirico, F., Nucera, G., & Magnavita, N. (2020). Estimating case fatality ratio during COVID-19 epidemics: Pitfalls and alternatives. Journal of Infection in Developing Countries, 14(5), 438–439. https://doi.org/10.3855/jidc.12787.

Collatuzzo, G., De Palma, G., Violante, F. S., Porru, S., Larese Filon, F., Fabianova, E., Violán, C., Vimercati, L., Leustean, M., Rodriguez-Suarez, M. M., Sansone, E., Sala, E., Zunarelli, C., Lodi, V., Monaco, M. G. L., Spiteri, G., Negro, C., Beresova, J., Carrasco-Ribelles, L. A., … Boffetta, P. (2023). Temporal trends of COVID-19 antibodies in vaccinated healthcare workers undergoing repeated serological sampling: An individual-level analysis within 13 months in the ORCHESTRA cohort. Frontiers in Immunology, 13(January), 1–11. https://doi.org/10.3389/fimmu.2022.1079884.

Enciu, B. G., Pițigoi, D., Zaharia, A., Popescu, R., Niculcea, A., Crăciun, M. D., & Pistol, A. (2023). COVID-19 Vaccination in Romania and the Benefits of the National Electronic Registry of Vaccinations. Vaccines, 11(2), 1–12. https://doi.org/10.3390/vaccines11020370.

Fang, E., Liu, X., Li, M., Zhang, Z., Song, L., Zhu, B., Wu, X., Liu, J., Zhao, D., & Li, Y. (2022). Advances in COVID-19 mRNA vaccine development. Signal Transduction and Targeted Therapy, 7(1), 1–31. https://doi.org/10.1038/s41392-022-00950-y.

Filip, R., Gheorghita Puscaselu, R., Anchidin-Norocel, L., Dimian, M., & Savage, W. K. (2022). Global Challenges to Public Health Care Systems during the COVID-19 Pandemic: A Review of Pandemic Measures and Problems. Journal of Personalized Medicine, 12(8). https://doi.org/10.3390/jpm12081295.

García-Botella, A., García-Lledó, A., Gómez-Pavón, J., Del Castillo, J. G., Hernández-Sampelayo, T., Martín-Delgado, M. C., Sánchez, F. J. M., Martínez-Sellés, M., García, J. M. M., Guillén, S. M., Rodríguez-Artalejo, F., Ruiz-Galiana, J., Cantón, R., Ramos, P. D. L., & Bouza, E. (2022). Booster or additional vaccination doses in patients vaccinated against COVID-19. Revista Espanola de Quimioterapia, 35(2), 105–114. https://doi.org/10.37201/req/149.2021.

Garg, I., Sheikh, A. B., Pal, S., & Shekhar, R. (2022). Mix-and-Match COVID-19 Vaccinations (Heterologous Boost): A Review. Infectious Disease Reports, 14(4), 537–546. https://doi.org/10.3390/idr14040057.

Gerhards, C., Thiaucourt, M., Hetjens, M., Haselmann, V., Neumaier, M., & Kittel, M. (2023). Heterologous Vector—mRNA Based SARS-CoV-2 Vaccination Strategy Appears Superior to a Homologous Vector—Based Vaccination Scheme in German Healthcare Workers Regarding Humoral SARS-CoV-2 Response Indicating a High Boosting Effect by mRNA Vaccines. Vaccines, 11(3), 1–17. https://doi.org/10.3390/vaccines11030701.

Grewal, R., Kitchen, S. A., Nguyen, L., Buchan, S. A., Wilson, S. E., Costa, A. P., & Kwong, J. C. (2022). Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: Test negative design study. The BMJ. https://doi.org/10.1136/bmj-2022-071502.

Hafiz, I., Illian, D. N., Meila, O., Utomo, A. R. H., Susilowati, A., Susetya, I. E., Desrita, D., Siregar, G. A., & Basyuni, M. (2022). Effectiveness and Efficacy of Vaccine on Mutated SARS-CoV-2 Virus and Post Vaccination Surveillance: A Narrative Review. Vaccines, 10(1), 1–18. https://doi.org/10.3390/vaccines10010082.

Hasibuan, A. S., Koesnoe, S., Widhani, A., Muhadi, M., Shatri, H., Ginanjar, E., Yunihastuti, E., Soewondo, P., Aman Nasution, S., Djauzi, S., Dina Liastuti, L., Koento, T., Sumariyono, S., & Mulyantini, A. (2023). Incidence and Associated Factors of SARS-CoV-2 Infection Post-mRNA-1273 Booster Vaccination in Health-Care Workers. Vaccines, 11(2), 1–16. https://doi.org/10.3390/vaccines11020481.

Huang, M., He, R., Chen, Q., Song, J., Huang, H., & Zheng, S. (2023). COVID-19 vaccine booster dose hesitancy among key groups: A cross-sectional study. Human Vaccines and Immunotherapeutics, 19(1), 1–8. https://doi.org/10.1080/21645515.2023.2166323.

Jabessa, D., & Bekele, F. (2022). Willingness to receive the COVID-19 vaccine and associated factors among residents of Southwestern Ethiopia: A cross-sectional study. Patient Preference and Adherence, 16(May), 1177–1185. https://doi.org/10.2147/PPA.S362264.

Khong, K. W., Zhang, R., & Hung, I. F. N. (2022). The Four Ws of the Fourth Dose COVID-19 Vaccines: Why, Who, When and What. Vaccines, 10(11), 1–12. https://doi.org/10.3390/vaccines10111924.

Kitsios, F., Papageorgiou, E., Kamariotou, M., Perifanis, N. A., & Talias, M. A. (2022). Emotional intelligence with the gender perspective in health organizations managers. Heliyon, 8(11). https://doi.org/10.1016/j.heliyon.2022.e11488.

Mahapatra, A. (2022). Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India. The Indian Journal of Medical Research, 156(2), 228–239. https://doi.org/https://doi.org/10.4103/ijmr.ijmr_3040_21.

Matrajt, L., Eaton, J., Leung, T., Dimitrov, D., Schiffer, J. T., Swan, D. A., & Janes, H. (2021). Optimizing vaccine allocation for COVID-19 vaccines shows the potential role of single-dose vaccination. Nature Communications, 12(1). https://doi.org/10.1038/s41467-021-23761-1.

Mattiuzzi, C., & Lippi, G. (2023). Efficacy of the Second COVID-19 Vaccine Booster Dose in the Elderly. Vaccines, 11(2), 1–6. https://doi.org/10.3390/vaccines11020213.

Matzaraki, V., Kumar, V., Wijmenga, C., & Zhernakova, A. (2017). The MHC locus and genetic susceptibility to autoimmune and infectious diseases. Genome Biology, 18(1). https://doi.org/10.1186/s13059-017-1207-1.

Megatsari, H., Kusuma, D., Ernawaty, E., & Putri, N. K. (2022). Geographic and Socioeconomic Inequalities in Delays in COVID-19 Vaccinations: A Cross-Sectional Study in Indonesia. Vaccines, 10(11), 1–13. https://doi.org/10.3390/vaccines10111857.

Menni, C., May, A., Polidori, L., Louca, P., Wolf, J., Capdevila, J., Hu, C., Ourselin, S., Steves, C. J., Valdes, A. M., & Spector, T. D. (2022). COVID-19 vaccine waning and effectiveness and side-effects of boosters: a prospective community study from the ZOE COVID Study. The Lancet Infectious Diseases, 22(7), 1002–1010. https://doi.org/10.1016/S1473-3099(22)00146-3.

Miller, J. D., Ackerman, M. S., Laspra, B., Polino, C., & Huffaker, J. S. (2022). Public attitude toward Covid-19 vaccination: The influence of education, partisanship, biological literacy, and coronavirus understanding. FASEB Journal, 36(7), 1–14. https://doi.org/10.1096/fj.202200730.

Pérez-Alós, L., Armenteros, J. J. A., Madsen, J. R., Hansen, C. B., Jarlhelt, I., Hamm, S. R., Heftdal, L. D., Pries-Heje, M. M., Møller, D. L., Fogh, K., Hasselbalch, R. B., Rosbjerg, A., Brunak, S., Sørensen, E., Larsen, M. A. H., Ostrowski, S. R., Frikke-Schmidt, R., Bayarri-Olmos, R., Hilsted, L. M., … Garred, P. (2022). Modeling of waning immunity after SARS-CoV-2 vaccination and influencing factors. Nature Communications, 13(1), 1–11. https://doi.org/10.1038/s41467-022-29225-4.

Qin, C., Yan, W., Du, M., Liu, Q., Tao, L., Liu, M., & Liu, J. (2022). Acceptance of the COVID-19 vaccine booster dose and associated factors among the elderly in China based on the health belief model (HBM): A national cross-sectional study. Frontiers in Public Health, 10. https://doi.org/10.3389/fpubh.2022.986916.

Reisch, T., Heiler, G., Hurt, J., Klimek, P., Hanbury, A., & Thurner, S. (2021). Behavioral gender differences are reinforced during the COVID-19 crisis. Scientific Reports, 11(1), 1–12. https://doi.org/10.1038/s41598-021-97394-1.

Salah, H., Sinan, I., Alsamani, O., Abdelghani, L. S., ElLithy, M. H., Bukamal, N., Jawad, H., Hussein, R. R. S., Elgendy, M. O., Rabie, A. shaimaa I., Khalil, D. M., Said, A. S. A., AlAhmad, M. M., & Khodary, A. (2023). COVID-19 Booster Doses: A Multi-Center Study Reflecting Healthcare Providers’ Perceptions. Vaccines, 11(6), 1061. https://doi.org/10.3390/vaccines11061061.

Satari, H. I., Kaswandani, N., Medise, B. E., Sundoro, J., Hadinegoro, S. R., Leonard, E., Putra, A., & Angkasa, P. F. (2023). Safety profile of inactivated COVID-19 vaccine in indonesian adults. Vaccine: X, 14, 100331. https://doi.org/10.1016/j.jvacx.2023.100331.

Stefanelli, P., & Rezza, G. (2022). COVID-19 Vaccination Strategies and Their Adaptation to the Emergence of SARS-CoV-2 Variants. Vaccines, 10(6), 1–10. https://doi.org/10.3390/vaccines10060905.

Theparod, T., Kreabkhontho, P., & Teparos, W. (2023). Booster Dose Vaccination and Dynamics of COVID-19 Pandemic in the Fifth Wave: An Efficient and Simple Mathematical Model for Disease Progression. Vaccines, 11(3). https://doi.org/10.3390/vaccines11030589.

Wang, J., Deng, C., Liu, M., Liu, Y., Li, L., Huang, Z., Shang, L., Jiang, J., Li, Y., Mo, R., Zhang, H., Liu, M., Peng, S., & Xiao, H. (2022). A fourth dose of the inactivated SARS-CoV-2 vaccine redistributes humoral immunity to the N-terminal domain. Nature Communications, 13(1). https://doi.org/10.1038/s41467-022-34633-7.

Wong, M. T. J., Dhaliwal, S. S., Balakrishnan, V., Nordin, F., Norazmi, M. N., & Tye, G. J. (2023). Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia. International Journal of Environmental Research and Public Health, 20(2). https://doi.org/10.3390/ijerph20021647.

Yamamoto, K. (2022). Adverse effects of COVID-19 vaccines and measures to prevent them. Virology Journal, 19(1), 1–3. https://doi.org/10.1186/s12985-022-01831-0.

Zychlinsky Scharff, A., Paulsen, M., Schaefer, P., Tanisik, F., Sugianto, R. I., Stanislawski, N., Blume, H., Schmidt, B. M. W., Heiden, S., Stiesch, M., & Melk, A. (2022). Students’ age and parental level of education influence COVID-19 vaccination hesitancy. European Journal of Pediatrics, 181(4), 1757–1762. https://doi.org/10.1007/s00431-021-04343-1.